 |
市場調査レポート
商品コード
1373802
バイオサージェリーの世界市場 - 市場規模、シェア、成長分析：タイプ別（外科用シーラント、接着剤） - 業界予測（2023年～2030年）Global Biosurgery Market Size, Share, Growth Analysis, By Type(Surgical sealants, adhesives) - Industry Forecast 2023-2030 |
||||||
| バイオサージェリーの世界市場 - 市場規模、シェア、成長分析：タイプ別（外科用シーラント、接着剤） - 業界予測（2023年～2030年） |
|
出版日: 2023年10月24日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のバイオサージェリーの市場規模は2021年に138億9,000万米ドル、2022年に145億6,000万米ドルとなりました。同市場は、予測期間中（2023年～2030年）に6.9％のCAGRで拡大し、2030年には242億1,000万米ドルに成長する見通しです。
世界のバイオサージェリー市場は、手術手技の進歩や低侵襲手術に対する需要の高まりに牽引され、著しい成長と変貌を遂げています。バイオサージェリーには、治癒と手術結果の向上を目的とした、シーラント、止血剤、軟組織修復材などの生物学的製品の使用が含まれます。この成長は、手術件数の増加、慢性疾患の有病率の増加、高齢化によって促進されています。さらに、個別化医療の採用と革新的な生物製剤の開拓は、厳しい規制要件と製品コストによる課題にもかかわらず、市場の拡大をさらに後押ししています。結論として、世界のバイオサージェリー市場は、先進的外科手術ソリューションの開発と商業化において、企業に有望な機会を提供しています。
世界のバイオサージェリー市場は、低侵襲手術手技の人気の高まりによって大きく後押しされており、外傷の減少、回復の早さ、傷跡の少なさなどの利点からバイオサージェリー製品を活用しています。低侵襲手術に対する患者や外科医の嗜好の高まりは、革新的な生体材料や手術用シーラントなどの技術的進歩とともに、市場の成長に寄与しています。
世界のバイオサージェリー市場が直面している主な障害は、規制上の前提条件が厳しく、新製品に対する承認手続きが長期化していることです。バイオサージェリー製品に適用される規制は、広範な試験、臨床試験、安全性と有効性の基準の遵守を必要とし、その結果、大幅な遅延と開発費の上昇を招く。このような複雑な規制状況は、メーカーが新製品を革新して発売する妨げとなる可能性があり、規制順守と製品開拓に関連する多額の費用は中小企業の市場参入を妨げ、市場拡大の障害となる可能性があります。
当レポートは、世界のバイオサージェリー市場について調査し、市場の概要とともに、タイプ別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
目次
エグゼクティブサマリー
親市場分析
市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 動向分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
- トップ投資分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- ポーター分析
世界のバイオサージェリー市場、タイプ別
- 市場概要
- 外科用シーラント
- 接着剤
- 止血剤
- 軟組織パッチ
- 骨移植片代替品
世界のバイオサージェリー市場、地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
競合情勢
- 主要企業プロファイル
- Johnson & Johnson
- Baxter International Inc.
- Medtronic plc
- Integra LifeSciences Holdings Corporation
- B. Braun Melsungen AG
- Stryker Corporation
- Ethicon, Inc.
- Smith &Nephew plc
- Olympus Corporation
- CR Bard, Inc.
- Zimmer Biomet Holdings, Inc.
- BD
- Atrium Medical Corporation
- Maquet Holding BV &Co. KG
- CryoLife, Inc.
- Johnson Matthey
- CSL Limited
- Biotime, Inc.
- Cohera Medical, Inc.
- Sanofi S.A
Global Biosurgery Market size was valued at USD 13.89 billion in 2021 and is poised to grow from USD 14.56 billion in 2022 to USD 24.21 billion by 2030, growing at a CAGR of 6.9% in the forecast period (2023-2030).
The global biosurgery market is undergoing significant growth and transformation, driven by advancements in surgical techniques and the rising demand for minimally invasive procedures. Biosurgery entails the use of biological products like sealants, hemostatic agents, and soft tissue repair materials to enhance healing and surgical outcomes. This growth is fueled by increasing surgical volumes, a higher prevalence of chronic illnesses, and an aging population. Furthermore, the adoption of personalized medicine and the development of innovative biologics are further boosting market expansion, despite challenges posed by strict regulatory requirements and product costs. In conclusion, the global biosurgery market offers promising opportunities for companies in the development and commercialization of advanced surgical solutions.
Top-down and bottom-up approaches were used to estimate and validate the size of the global biosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report
The global biosurgery market is segmented by type and region. Based on type, the market can be segmented into surgical sealants, adhesives, hemostatic agents, soft tissue patches, and bone graft substitutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers:
Increasing Demand for Minimally Invasive Surgical Procedures
The global biosurgery market is significantly propelled by the rising popularity of minimally invasive surgical techniques, which leverage biosurgery products for their advantages like reduced trauma, quicker recovery, and minimal scarring. This increasing preference among patients and surgeons for minimally invasive procedures, along with technological advancements like innovative biomaterials and surgical sealants, contributes to the market's growth.
Restraints:
Regulatory Requirements and Lengthy Approval Processes for New Products
A key obstacle confronting the global biosurgery market is the stringent regulatory prerequisites and protracted approval procedures for novel products. The regulations governing biosurgery items necessitate extensive testing, clinical trials, and adherence to safety and effectiveness criteria, resulting in substantial delays and elevated development expenses. This intricate regulatory landscape can impede manufacturers from innovating and launching new products, while the considerable expenses linked to regulatory adherence and product development may obstruct the entry of small and medium-sized enterprises into the market, creating a hurdle to market expansion.
Market Trends:
A notable trend in the global biosurgery market is the increasing adoption of minimally invasive surgical approaches, which present numerous benefits such as smaller incisions, reduced scarring, faster recovery, and fewer postoperative complications compared to traditional open surgeries. Consequently, there is a rising need for biosurgical products tailored for minimally invasive procedures, driven by the growing preference among patients and healthcare providers for less invasive treatments with comparable or superior outcomes. In response to this trend, biosurgery market manufacturers are prioritizing the development of innovative products and techniques to meet the escalating demand and improve patient satisfaction.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Biosurgery Market by Type
- Market Overview
- Surgical sealants
- adhesives
- hemostatic agents
- soft tissue patches
- and bone graft substitutes
- Global Biosurgery Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integra LifeSciences Holdings Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ethicon, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- C.R. Bard, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BD (Becton, Dickinson and Company) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Atrium Medical Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Maquet Holding B.V. & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CryoLife, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson Matthey (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CSL Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biotime, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cohera Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
